PNTG · Pennant Group, Inc.

Track PNTG — free

$38.88 -0.12 (-0.31%) At close · Aug 21

Market Cap

$1.36B

34.93M

Up next

Next earnings call

Nov 6, 2026 Est · unconfirmed · in 11 wks

FQ3-26 quarter ends

~Sep 30, 2026 Est

Latest filing: 10-Q

filed Aug 5, 2026

AI Brief

TL;DR.

Bullish

Bearish

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Ask ALVIS about this →

Equibles Rating

blended score · not investment advice

Overall

Buy

SellHoldBuy

Technical Buy Momentum Strong Sentiment Bullish Fundamentals Strong Quant / Vol Moderate

Market backdrop VIX 15.1 · calm Equity put/call 0.51

Technical

price trend

Buy

50 / 200-day cross No cross

Price vs 200-day avg +20%

above

Price vs 50-day avg +1%

above

RSI (14) 48

neutral

MACD trend Negative

52-week position 83%

mid-range

Momentum

relative strength

Strong

1-month return −6%

trailing

6-month return +15%

trailing

YTD return +38%

this year

Relative strength +3%

vs S&P · 6-mo

Sentiment

smart money

Bullish

Trend (MA cross) No cross

50d $38 › 200d $32 — 50d above 200d

Institutional flow Accumulating

+5% holders QoQ · +39 funds added

Insider flow Distributing

Net -$218.7K over 90 days · 100% sells

Short interest Falling

1.91% of float · ▼ -8.0% MoM · 2.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

200 holders — near 3-yr high, broad support

Squeeze score 45

elevated · 0–100

Fundamentals

Strong

Revenue growth +36%

Y/Y

EPS growth +20%

Y/Y

Free cash flow $36.3M

Valuation P/E 42.7

rich

Buyback $1.0M

authorized

Balance sheet $168.8M

net debt

Quant / Vol

risk profile

Moderate

Volatility 37%

annualized · 1-yr

Max drawdown −18%

past year

ATR 3.4%

of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

what management promised — and delivered

Beat or met 3 of last 3

Latest guidance · from the 8-K filed Aug 5, 2026

Total revenue · full year 2026 Initiated $1.17B – $1.19B

prior FY $947.71M midpoint +24.6% Y/Y

Adjusted earnings per diluted share · full year 2026 Non-GAAP Initiated $1.34 – $1.41

Adjusted EBITDA · full year 2026 Non-GAAP Initiated $94.4M – $98M

Adjusted EBITDA prior to NCI · full year 2026 Non-GAAP Initiated $101.5M – $105.1M

Prior guidance period ended · from the 8-K filed Nov 5, 2025

Total revenue · full year 2025 $911.4M – $948.6M

Adjusted EBITDA · full year 2025 $70.9M – $73.8M

Adjusted earnings per diluted share · full year 2025 $1.14 – $1.18

Guided vs delivered · last 3 settled

Total revenue full year 2025

guided $911.4M – $948.6M

guided $911.4M – $948.6M $947.71M In line

Revenue full year 2024

guided $596.8M – $633.7M

guided $596.8M – $633.7M $695.24M Beat +13.0%

Revenue full year 2023

guided $526M – $531M

guided $526M – $531M $544.89M Beat +3.1%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy

1 · 3 · 2

50 / 200-day cross

No cross Neutral

Price vs 200-day avg

+20% Bullish

Price vs 50-day avg

+1% Bullish

RSI (14)

48 Neutral

MACD trend

Negative Bearish

52-week position

83% Neutral

Market signals — smart money & positioning

Bullish · 3 of 6

Trend (MA cross) No cross

50d $38 › 200d $32 — 50d above 200d

Institutional flow Accumulating

+5% holders QoQ · +39 funds added

Insider flow Distributing

Net -$218.7K over 90 days · 100% sells

Short interest Falling

1.91% of float · ▼ -8.0% MoM · 2.9 days cover

Volume signal Normal

Volume near normal

Institution breadth Multi-yr high

200 holders — near 3-yr high, broad support

Price context

position in its 52-week range

Range low $24 Now $39 · 83% Range high $42

vs 200-day avg +20% vs 50-day avg +1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings

Metric	Latest	Period	YoY
Adjusted net income non-GAAP	12.8M	second quarter of 2026	—

Average daily census	5,339	Six Months Ended June 30, 2026	—

Average Medicare revenue per 60-day completed episode	$3,689	Six Months Ended June 30, 2026	—
average monthly revenue per occupied room	$5,392	second quarter of 2026	—

Average monthly revenue per occupied unit	$5,390	Six Months Ended June 30, 2026	—
average occupancy	78.9%	second quarter of 2026	—
Consolidated Adjusted EBITDA non-GAAP	$45.98M	Six Months Ended June 30, 2026	—

Consolidated Adjusted EBITDA prior to NCI non-GAAP	$49.57M	Six Months Ended June 30, 2026	—

Consolidated Adjusted EBITDAR non-GAAP	37.6M	second quarter of 2026	—

GAAP → non-GAAP reconciliation GAAP Consolidated Adjusted EBITDA $24.27M +$13.43M Rent—cost of services -$67K Rent related to items (a) and (d) above = Consolidated Adjusted EBITDAR $37.63M
Home Health and Hospice Services Segment Adjusted EBITDA from Operations non-GAAP	$71.33M	Six Months Ended June 30, 2026	—

Home Health and Hospice Services segment adjusted EBITDA from operations prior to NCI non-GAAP	39.6M	second quarter of 2026	—
Home Health and Hospice Services Segment Adjusted EBITDAR from Operations non-GAAP	$77.75M	Six Months Ended June 30, 2026	—

Hospice average daily census	5,477	second quarter of 2026	—

Hospice Medicare revenue per day	$191	Six Months Ended June 30, 2026	—
Non-GAAP net income non-GAAP	$24.37M	Six Months Ended June 30, 2026	—

Occupancy	78.7%	Six Months Ended June 30, 2026	—

same store average monthly revenue per occupied room	$5,413	second quarter of 2026	—
same store average occupancy	81.6%	second quarter of 2026	—
same store home health admissions	17,854	second quarter of 2026	—
same store hospice average daily census	4,089	second quarter of 2026	—
same store Medicare home health admissions	7,372	second quarter of 2026	—
Segment Adjusted EBITDAR from Operations non-GAAP	$109.98M	Six Months Ended June 30, 2026	—

Senior Living segment adjusted EBITDA from operations non-GAAP	5.8M	second quarter of 2026	—

Senior Living segment adjusted EBITDAR from operations non-GAAP	16M	second quarter of 2026	—

Senior Living Services Segment Adjusted EBITDA from Operations non-GAAP	$12.25M	Six Months Ended June 30, 2026	—
Senior Living Services Segment Adjusted EBITDAR from Operations non-GAAP	$32.23M	Six Months Ended June 30, 2026	—
Total home health admissions	59,668	Six Months Ended June 30, 2026	—

Total hospice admissions	9,649	Six Months Ended June 30, 2026	—
Total Medicare home health admissions	25,219	Six Months Ended June 30, 2026	—

Segment Adjusted EBITDA from Operations non-GAAP	$33.6M	Three Months Ended March 31	—
Senior Living average occupancy	78.6%	first quarter of 2026	—

Senior Living segment occupancy	79.7%	full year 2025	—

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Medical Care Facilities — same industry group

Open screener →

Company	Mkt cap	YTD	Rev growth Y/Y	P/E	Short % shares
PNTG Pennant Group, Inc. this stock	$1.36B	+38.1%	+36.3%	42.7	1.9%
HCA HCA Healthcare, Inc.	$95.21B	-8.1%	+7.1%	14.8	2.7%
FSNUY Fresenius SE & Co. KGaA	$30.73B	-4.8%	—	—	0.0%
THC Tenet Healthcare Corp	$22.61B	+41.3%	+0.9%	10.8	4.0%
FMS Fresenius Medical Care AG	$12.47B	-1.6%	+5.9%	—	0.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section

Ownership

Institutional Holders Accumulating

Holders

200

% held: 89.8%
Net QoQ: +176.0K sh
Top holder: BlackRock, Inc.

Held Float

View

Held by Funds

Fund positions

206

View

Short & Settlement

Short Interest Falling

Shares short

667.3K

Days to cover: 2.9d
Change: -57.7K sh

View

Short Volume

Short vol %

43%

As of: Aug 21, 2026

Short Total

View

Fails to Deliver

FTD shares

3.9K

Value: $162.7K
As of: Jul 17, 2026

View

Off-Exchange

Off-exchange %

46.0%

Week of: Jul 13, 2026

Off-exch Lit

View

Smart Money

Insider Trades Net selling

Net (90d)

-$218.7K

Buyers / Sellers: 0 / 2

Buyers Sellers

View

Financials

Revenue (FY)

$947.7M

Net income (FY): $29.6M
EPS diluted: $0.84

View

Buybacks

Authorized

$1.0M

View

Filings

SEC Filings

Latest

8-K

Filed: Aug 5, 2026
This year: 8

View

Proposed Sales

Value

$165.1K

Shares: 4.3K
Filed: Aug 6, 2026

View

Earnings & Events

Earnings Calls

Last call

Aug 6, 2026

View

Investor Relations

Performance

	5D	20D	120D	MTD	YTD
PNTG	-1.1%	-5.5%	+15.0%	-3.6%	+38.1%
SPY	-1.4%	+3.6%	+11.6%	+2.5%	+12.3%
vs SPY	+0.3%	-9.2%	+3.4%	-6.1%	+25.8%

Capital returns

Buyback program · as of Dec 12, 2022

Authorized

$1.00M

Spent (derived)

—

Remaining

—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1766400 CUSIP 70805E109 13F (30d) 184 filings 180 filers Visit website Investor relations

PNTG · Pennant Group, Inc.

Price & Indicators

Up next

AI Brief

Equibles Rating

Guidance & track record

Technicals

Key metrics

Versus peers

At a glance

Performance

Capital returns